Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000070858-26-000531·Mereo BioPharma Group plc
Schedule 13G ownership disclosure
Mereo BioPharma Group plc
Ordinary Shares · CUSIP: G6014T100
Event date: 2026-09-30
- Filing-level shares
- 26,889,300.00
- Percent of class
- 3.4%
- BANK OF AMERICA CORP /DE/
Shares: 26,889,300.00 · Class: 3.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000070858-26-000531
- Form type
- SCHEDULE 13G/A
- Filer
- Mereo BioPharma Group plc
- CIK
- CIK 1719714
- Filed
- Oct 28, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership